CLINICAL_TRIALS
trial_result
· 2025-01-15
Clinical Trial Update: Study of the AFB and Stenting of the Iliac Arteries [Phase 1]
Summary
Phase 1 study evaluating AFB and iliac artery stenting for aortoiliac segment lesions (TASC II C/D) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Aorta-iliac Segment Lesion (C,D Type by TASC II) | Phase 1 | Status: COMPLETED